Performance of the microscopic observation drug susceptibility assay in pyrazinamide susceptibility testing for Mycobacterium tuberculosis

Chinese Medical Journal

Volumn 126, Issue 22, 2013, Pages 4334-4339

  Huang, Zi Kun ^a   Luo, Qing ^a   Jiang, Bi Xia ^a   Li, Wei Ting ^a   Xu, Xiao Meng ^a   Xiong, Guo Liang ^b   Li, Jun Ming ^a  

^a NANCHANG UNIVERSITY   (China)

^b Children's Hospital of Jiangxi Province   (China)

Author keywords

Microscopic observation drug susceptibility; Mycobacterium tuberculosis; Pyrazinamide; Susceptibility test

Indexed keywords

PYRAZINAMIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM CULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENE MUTATION; GENE SEQUENCE; MICROBIOLOGICAL EXAMINATION; MICROSCOPIC OBSERVATION DRUG SUSCEPTIBILITY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PNCA GENE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; WAYNE ASSAY;

ANTITUBERCULAR AGENTS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PYRAZINAMIDE;

EID: 84887601441     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20130108     Document Type: Article

References (25)

1. Migliori GB, Loddenkemper R, Blasi F, Raviglione MC. 125 years after Robert Koch's discovery of the tubercle bacillus: the new XDR TB threat. Is "science" enough to tackle the epidemic? Eur Respir J 2007; 29:423-427.
2. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. Geneva, Switzerland: WHO; 2010.
3. World Health Organization. Global tuberculosis control surveillance, planning, financing. Report WHO/HTM/TB/2005. 349. Geneva: World Health Organization; 2005.
4. Konno K, Feldmann FM, McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis 1967; 95: 461-469.
5. Heifets L. Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide. J Med Microbiol 2002; 51: 11-12.
6. Trivedi SS, Desai SG. Pyrazinamidase activity of Mycobacterium tuberculosis: a test of sensitivity to pyrazinamide. Tubercle 1987; 68: 221-224.
7. Singh P, Wesley C, Jadaun GP, Malonia SK, Das R, Upadhyay P, et al. Comparative evaluation of Löwenstein Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol 2007; 45: 76-80.
8. CLSI. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes. 2nd ed. Approved standard. CLSI document M24 A2. Wayne: Clinical and Laboratory Standards Institute; PA. 2011.
9. Chang KC, Yew WW, Zhang Y. Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta analyses. Antimicrob Agents Chemother 2011; 55: 4499-4505.
10. Chedore P, Bertucci L, Wolfe J, Sharma M, Jamieson F. Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. J Clin Microbiol 2010; 48: 300-301.
11. Butler WR, Kilburn JO. Susceptibility of Mycobacterium tuberculosis to pyrazinamide and its relationship to pyrazinamidase activity. Antimicrob Agents Chemother 1983; 24: 600-601.
12. Miller MA, Thibert L, Desjardins F, Siddiqi SH, Dascal A. Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide: comparison of Bactec method with pyrazinamidase assay. J Clin Microbiol 1995; 33: 2468-2470.
13. Wayne LG. Simple pyrazinamidase and urease tests for routine identification of mycobacteria. Am Rev Respir Dis 1974; 109: 147-151.
14. Mirabal NC, Yzquierdo SL, Lemus D, Madruga M, Milián Y, Echemendía M, et al. Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis. J Clin Microbiol 2010; 48: 2729-2733.
15. Krishnamurthy A, Almeida D, Rodrigues C, Mehta A. Comparison of pyrazinamide drug susceptibility of M. tuberculosis by radiometric BACTEC and enzymatic pyrazinamidase assay. Indian J Med Microbiol 2004; 22: 166 168.
16. Davies AP, Billington OJ, McHugh TD, Mitchison DA, Gillespie SH. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing with Mycobacterium tuberculosis. J Clin Microbiol 2000; 38: 3686-3688.
17. Caviedes L, Lee TS, Gilman RH, Sheen P, Spellman E, Lee EH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38: 1203-1208.
18. Park WG, Bishai WR, Chaisson RE, Dorman SE. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 4750-4752.
19. Moore DA, Evans CA, Gilman RH, Caviedes L, Coronel J, Vivar A, et al. Microscopic observation drug susceptibility assay for the diagnosis of TB. N Engl J Med 2006;355:1539-155.
20. Coronel J, Roper M, Mitchell S, Castillo E, Gamarra N, Drobniewski F, et al. MODS accreditation process for regional reference laboratories in Peru: validation by GenoType® MTBDRplus. Int J Tuberc Lung Dis 2010; 14: 1475-1480.
21. Ghiraldi LD, Campanerut PA, Spositto FL, Sato DN, Leite CQ, Hirata M, et al. Evaluation of the microscopic observation drug susceptibility assay for detection of Mycobacterium tuberculosis resistance to pyrazinamide. Clin Microbiol Infect 2011; 17: 1792-1797.
22. Barco P, Cardoso RF, Hirata RD, Leite CQ, Pandolfi JR, Sato DN, et al. pncA mutations in pyrazinamide resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 2006; 58: 930-935.
23. Tripathy SP, Mitchison DA, Nair NG, Radhakrishna S, Subbammal S. A comparison of various measures of sensitivity of M. tuberculosis to pyrazinamide. Tubercle 1970; 51: 375-388.
24. Van Soolingen D, Hermans PW, de Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991; 29: 2578-2586.
25. Scorpio A, Lindholm Levy P, Heifets L, Gilman R, Siddiqi S, Cynamon M, et al. Characterization of pncA mutations in pyrazinamide resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 1997; 41: 540-543.